Table 2.
Clinical data and biochemical results for critical and non-critical COVID-19 patients.
| Hospitalized patients | ICU | Non-ICU | p |
|---|---|---|---|
| N, % | 24 (12.1%) | 175 (87.9%) | < 0.001 |
| Age (years) | 59.7 ± 12.1 | 58.8 ± 16.7 | 0.653 |
| DM (n, %) | 6/24 (25.0) | 21/175 (12.0) | 0.018 |
| HT (n, %) | 11/24 (45.8) | 64/175 (36.8) | 0.379 |
| Obesity (n, %) | 6/24 (25.0) | 13/175 (7.4) | 0.006 |
| CKD (n, %) | 2/24 (8.3) | 13/175 (7.4) | 0.873 |
| HF (n, %) | 0/24 (0.0) | 1/175 (0.6) | 0.711 |
| AKI (n, %) | 4/24 (16.7) | 11/175 (6.3) | 0.009 |
| Non-survivors (n, %) | 6/24 (25.0) | 14/175 (8.0) | 0.001 |
| Significant parameters | |||
| Male (n, %) | 21/24 (87.5) | 100/175 (57.1) | 0.004 |
| Specific weight | 1.028 ± 0.011 | 1.021 ± 0.009 | 0.002 |
| Urine glucose presence (n, %) | 5/24 (20.8) | 9/175 (5.1) | 0.005 |
| Urine protein presence (n, %) | 20/24 (83.3) | 80/175 (45.7) | 0.001 |
| Urine ketones presence (n, %) | 3/24 (12.5) | 5/175 (2.9) | 0.024 |
| Granular casts (cast/uL) | 0.6 (1.2) | 0.1 (0.4) | 0.030 |
| Hemoglobin (g/dL) | 15.0 ± 1.6 | 14.2 ± 1.7 | 0.047 |
| D-Dimer (ng/mL) | 435 (576) | 229 (216) | 0.049 |
| Serum creatinine (mg/dL) | 0.95 (0.33) | 0.81 (0.29) | 0.032 |
| Serum Sodium (mmol/L) | 134 (4) | 138 (4) | < 0.001 |
| Serum Albumin (g/L) | 33.5 ± 4.3 | 36.8 ± 3.8 | < 0.001 |
| LDH (U/L) | 413 (225) | 303 (147) | < 0.001 |
| CRP (mg/dL) | 11.89 (15.22) | 6.41 (9.33) | 0.027 |
Quantitative variables were described by mean ± standard deviation or median (IQR); DM, Diabetes; HT, Hypertension; CKD, Chronic kidney disease; HF, heart failure; ICU, Intensive Care Unit; AKI, Acute Kidney Injury; LDH, lactate dehydrogenase; CRP, C-reactive protein.